Orencia Directject Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 13 years ago on Monday, March 21, 2011, according to the United State Patent & Trademark Office
Word Mark Orencia Directject
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 77218643
Status Date Monday, March 21, 2011
Filing Date Monday, March 21, 2011
Attorney Tanya Fickenscher Leonard

Correspondent

Tanya Fickenscher Leonard
Bristol-Myers Squibb Company
Trademark Department
345 Park Avenue
New York NY 10154

Case File Statements

Goods & Services Syringe Pre-Filled with Pharmaceutical Preparations for Treating Auto-Immune Diseases for Human Use
Pseudo Mark Orencia Direct Injection

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, July 3, 2007
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.